2014 Fiscal Year Final Research Report
New cell therapy for kidney disease using human kidney derived iPS cells
| Project/Area Number |
23591184
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HISHIKAWA Keiichi 東京大学, 大学院医学研究科, 特任准教授 (50255460)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
FUJITA Toshiro 東京大学, 先端研, 特任教授 (10114125)
ABRATANI Hiroyuki 東京大学, 先端研, 教授 (10202657)
|
|---|
| Project Period (FY) |
2011-04-28 – 2015-03-31
|
| Keywords | iPS 細胞 / 腎臓 |
|---|
| Outline of Final Research Achievements |
Human pluripotent cells are promising for treatment for kidney diseases, but the protocols for derivation of kidney cell types are still controversial. In this study, we tried to establish new cell therapy for kidney disease by using human kidney derived iPS cells. We induced kidney lineage cells from iPS cells and confirmed improvement of kidney function by using the cells.
|
| Free Research Field |
再生医学
|
